Using molecular and neuropathological measures and TDP-43 enhanced crosslinking and immunoprecipitation sequencing (eCLIP-seq) and m6A eCLIP-seq, we determined that mHTT disrupts TDP-43 and METTL3 function in post-transcriptional processing of their RNA targets in HD. This evidence concerns the gene METTL3 and Huntington disease.